NCT00819767 - Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Aliskiren was supplied in 150 mg tablets.

DRUG

Valsartan

Valsartan was supplied in 160 mg capsules.

DRUG

Placebo to aliskiren

Placebo to aliskiren was supplied in tablets matching aliskiren 150 mg.

DRUG

Placebo to valsartan

Placebo to valsartan was supplied in capsules matching valsartan 160 mg.

Trial Locations (8)

Investigative Site, Pardubice

Investigative Site, Prague

Investigative Site, Budapest

Investigative Site, Nyíregyháza

Investigative Site, Pilisvörösvár

Investigative Site, Szentendre

Investigative Site, Singapore

Investigative Site, Leicester